0001093557-15-000186.txt : 20150605 0001093557-15-000186.hdr.sgml : 20150605 20150605184147 ACCESSION NUMBER: 0001093557-15-000186 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150603 FILED AS OF DATE: 20150605 DATE AS OF CHANGE: 20150605 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DEXCOM INC CENTRAL INDEX KEY: 0001093557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330857544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582000200 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FOLETTA MARK G CENTRAL INDEX KEY: 0001236389 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51222 FILM NUMBER: 15917056 MAIL ADDRESS: STREET 1: AMYLIN PHARMACEUTICALS INC STREET 2: 9360 TOWNE CENTRE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2015-06-03 0 0001093557 DEXCOM INC DXCM 0001236389 FOLETTA MARK G 6340 SEQUENCE DRIVE SAN DIEGO CA 92121 1 0 0 0 Common Stock 2015-06-03 4 A 0 4671.0 0.0010 A 11993 D Share units are restricted and subject to vesting in one annual installment from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. common stock. Included in this number are 11,537 unvested restricted stock units, 4,671 of which were granted on June 3, 2015 and will vest on June 3, 2016 and 6,866 unvested restricted stock units granted on November 17, 2014 and shall vest through November 17, 2017. By: John D. Lister For: Mark G. Foletta 2015-06-05